Prospective determination of plasma imipenem concentrations in critically ill children.


Autoria(s): Giannoni E.; Moreillon P.; Cotting J.; Moessinger A.; Bille J.; Décosterd L.; Zanetti G.; Majcherczyk P.; Bugnon D.
Data(s)

2006

Resumo

Plasma imipenem concentrations were measured in 19 critically ill children (median age, 0.8 year; range, 0.02 to 12.9 years). Wide interindividual variations (2 to 4x at peak and >10x at trough concentrations) resulted in unpredictable plasma levels in several children. To avoid subtherapeutic drug levels, we recommend treatment with at least 100 mg/kg of body weight/day of imipenem-cilastatin for critically ill children requiring such therapy.

Identificador

http://serval.unil.ch/?id=serval:BIB_E2F1AB540BD5

isbn:0066-4804[print], 0066-4804[linking]

pmid:16801447

doi:10.1128/AAC.01149-05

isiid:000238721200046

Idioma(s)

en

Fonte

Antimicrobial Agents and Chemotherapy, vol. 50, no. 7, pp. 2563-2568

Palavras-Chave #Anti-Bacterial Agents/administration & dosage; Area Under Curve; Bacterial Infections/drug therapy; Bacterial Infections/microbiology; Child; Child, Preschool; Cilastatin/administration & dosage; Critical Illness; Cross Infection/drug therapy; Cross Infection/microbiology; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem/administration & dosage; Imipenem/pharmacokinetics; Infant; Infant, Newborn; Infusions, Intravenous; Male
Tipo

info:eu-repo/semantics/article

article